KNOXVILLE, TN, May 25, 2021 ( ) – Provectus (OTCQB: PVCT) today announced that the State of Tennessee, as part of its fiscal year 2021-2022 budget, has directed funding in the amount of $2.5 million to develop animal health drug products through partnerships with state universities that have agriculture and veterinary medicine programs and th
State of Tennessee Awards Funding for Public-Private Partnership to Study Animal Cancers and Dermatological Disorders using Provectus’ Medical Science Platform
May 25, 2021 07:00 ET | Source: Provectus Biopharmaceuticals Inc. Provectus Biopharmaceuticals Inc. Knoxville, UNITED STATES
KNOXVILLE, TN, May 25, 2021 (GLOBE NEWSWIRE) Provectus (OTCQB: PVCT) today announced that the State of Tennessee, as part of its fiscal year 2021-2022 budget, has directed funding in the amount of $2.5 million to develop animal health drug products through partnerships with state universities that have agriculture and veterinary medicine programs and the Knoxville-headquartered biotechnology company.
This study will pursue oncology, hematology, and dermatology treatments for companion and production animals, furthering research in these areas and eventual drug development. The foundation of this study is the Company’s halogenated xanthene me